Aprea Therapeutics

APRE

Aprea Therapeutics has been a target of short sellers for a while. The current short interest of 4.90% is significantly above the average of the last 12 months (1.14%).

Short Interest Trend

Share Price

Total NSP

4.90%

+4.86%

vs. last month

Also interesting? All insider buys at Aprea Therapeutics

Found an error? Questions? Ideas?